Eastern Europe Medical Cannabis Market, by Distribution Channel
| Label | Cannabidiol | Tetrahydrocannabinol |
|---|---|---|
| 2018 | 38.22 USD Mn | 13.97 USD Mn |
| 2019 | 36.16 USD Mn | 13.26 USD Mn |
| 2020 | 33.99 USD Mn | 12.5 USD Mn |
| 2021 | 64.47 USD Mn | 23.79 USD Mn |
| 2022 | 103.36 USD Mn | 38.25 USD Mn |
| 2023 | 165.66 USD Mn | 61.49 USD Mn |
| 2024 | 265.43 USD Mn | 98.83 USD Mn |
| 2025 | 531.49 USD Mn | 198.49 USD Mn |
| 2026 | 696.39 USD Mn | 260.86 USD Mn |
| 2027 | 894.84 USD Mn | 336.22 USD Mn |
Data Source: Wantstats Repository
Growth Outlook
- The 2027 portion of the Eastern Europe Medical Cannabis Market, by Derivative, 2018 market is on a steady long-term growth path. Segment value stands at roughly USD 957 Mn in 2026 and is projected to reach USD 1231 Mn by 2027 — a gain of about 29% over the forecast period, translating to a CAGR in the double digits.
- 2027: Cannabidiol accounts for 73% of the combined USD total across these 2 groups, the largest single share.
- What the regional split looks like (2026): Cannabidiol leads, holding roughly 73% of segment value — the single largest regional share. Tetrahydrocannabinol is the second-largest contributor.
- By 2027, Cannabidiol alone is expected to reach USD 895 Mn, with Tetrahydrocannabinol at USD 336 Mn.
Market Dynamics
2027: Cannabidiol accounts for 73% of the combined USD total across these 2 groups, the largest single share.
Tetrahydrocannabinol is runner-up at 336.22M USD — 62% off the lead.
Cannabidiol: 38.22M USD in 2018 to 894.84M USD by 2027, up 2241%.
Tetrahydrocannabinol climbs from 13.97M USD (2018) to 336.22M USD (2027), a 2307% gain.
Tetrahydrocannabinol grows fastest of the group, 2307% from 2018 to 2027 — starting smaller doesn't mean staying smaller at this pace.
Across the full group, the combined total moves from 52.19M USD in 2018 to 1.23B USD in 2027 — a 2259% change.
Reading A Multi-Series Chart
This is a comparison chart, 2 groups at once — the interesting question is usually how the gap between them changes, not the value of any single group in isolation.
A group with a small share can still matter most for the story — it is often the rate of change, not the current level, that is worth the closer look.
Use this chart to size the Eastern Europe Medical Cannabis market and to compare how fast it is expected to grow against adjacent markets — it works best as an input to a market-entry or investment decision, not as a standalone verdict.
The numbers here come from a market sizing model: historical revenue estimates up to the 2018 base year, then forecasts through 2027 using growth-rate assumptions for each segment. The underlying report explains the methodology in detail.
Unlock the Full Data
Get This Chart
Access the complete chart and underlying data to support your research, analysis, and business decisions.
Powering the world's best teams.
From next-gen startups to established enterprises.
Get in Touch
Let's work together
support@wantstats.comSee our work in action
Start your data driven journey with us!
What our clients say
Trusted by forward-thinking businesses
for data-driven intelligence



